Fate Therapeutics, Inc. - Common Stock (NQ: FATE )
1.405
-0.015
(-1.06%)
Streaming Delayed Price
Updated: 10:30 AM EST, Feb 6, 2025
Add to My Watchlist
All News about Fate Therapeutics, Inc. - Common Stock![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]()
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Fate Therapeutics, inc (FATE) Q3 2021 Earnings Call Transcript
November 05, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|